CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -80.0% | 1,000 | -60.0% | 0.00% | -100.0% |
| Q3 2020 | $5,000 | -96.0% | 2,500 | -89.0% | 0.00% | -80.0% |
| Q4 2019 | $124,000 | -3.1% | 22,800 | -13.3% | 0.01% | -23.1% |
| Q3 2019 | $128,000 | -29.7% | 26,300 | 0.0% | 0.01% | -35.0% |
| Q2 2019 | $182,000 | +87.6% | 26,300 | +97.7% | 0.02% | -37.5% |
| Q1 2019 | $97,000 | – | 13,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 397,168 | $43,888 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $3,366 | 0.00% |
| Tekla Capital Management LLC | 154,310 | $17,051 | 0.00% |
| McAdam, LLC | 10,006 | $6 | 0.00% |
| Aries Wealth Management | 15,400 | $1,702 | 0.00% |
| WELLS FARGO & COMPANY/MN | 342,084 | $37,800 | 0.00% |
| JPMORGAN CHASE & CO | 43,415 | $5 | 0.00% |
| NORTHERN TRUST CORP | 207,329 | $22,910 | 0.00% |
| PINNACLE ASSOCIATES LTD | 18,580 | $2,053 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |